The current price-to-earnings ratio for Mednax stock as of Jun 22, 2026 is 11.25. This is calculated based on the current EPS of $2.09 and the stock price of $23.52 per share. The P/E ratio has increased by 11% from the past four quarters average of 10.2.
The average historical PE ratio of Mednax for the last ten years is 15.14. The current PE ratio of 11.25 is 26% below the historical average. In the past ten years, MD's PE ratio was at its highest in the Mar 2019 quarter at 30.19, when the stock price was $27.17 and the EPS was $0.9. The lowest value was in the Sep 2025 quarter, when it reached 8.68 with a price of $16.75 and an EPS of $1.93.
Maximum annual increase: 17.14% in 2013
Maximum annual decrease: -27.34% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 10.86 | N/A | $21.39 | $1.97 |
| 2024 | N/A | N/A | $13.12 | -$1.19 |
| 2023 | N/A | N/A | $9.3 | -$0.73 |
| 2022 | 18.81 | 6.45% | $14.86 | $0.79 |
| 2021 | 17.67 | N/A | $27.21 | $1.54 |
| 2020 | N/A | N/A | $24.54 | -$9.44 |
| 2019 | N/A | N/A | $27.79 | -$18.44 |
| 2018 | 11.19 | -27.34% | $33 | $2.95 |
| 2017 | 15.4 | -18.69% | $53.44 | $3.47 |
| 2016 | 18.94 | -4.58% | $66.66 | $3.52 |
| 2015 | 19.85 | -3.31% | $71.66 | $3.61 |
| 2014 | 20.53 | 8.85% | $66.11 | $3.22 |
| 2013 | 18.86 | 17.14% | $53.38 | $2.83 |
| 2012 | 16.1 | 1.96% | $39.76 | $2.47 |
| 2011 | 15.79 | 1.87% | $36.01 | $2.28 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 10.23 | -5.8% | $21.39 | $2.09 |
| Dec 2025 | 10.86 | 25.12% | $21.39 | $1.97 |
| Sep 2025 | 8.68 | -20.73% | $16.75 | $1.93 |
| Jun 2025 | 10.95 | N/A | $14.35 | $1.31 |
| Mar 2025 | N/A | N/A | $14.49 | -$0.99 |
| Dec 2024 | N/A | N/A | $13.12 | -$1.19 |
| Sep 2024 | N/A | N/A | $11.59 | -$3.07 |
| Jun 2024 | N/A | N/A | $7.55 | -$3.04 |
| Mar 2024 | N/A | N/A | $10.03 | -$0.86 |
| Dec 2023 | N/A | N/A | $9.3 | -$0.73 |
| Sep 2023 | 11.35 | -1.73% | $12.71 | $1.12 |
| Jun 2023 | 11.55 | -6.25% | $14.21 | $1.23 |
| Mar 2023 | 12.32 | -34.5% | $14.91 | $1.21 |
| Dec 2022 | 18.81 | 105.13% | $14.86 | $0.79 |
| Sep 2022 | 9.17 | -38.04% | $16.51 | $1.8 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of MD is greater than its 3-year historical average, but it is lower than the 5 and 10-year averages.
With a P/E of 11.25, MD stands below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 24.1, Mednax's P/E is 53% lower.
MD's PE ratio is higher than its peer stocks THC and UHS.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CYH Community Health Systems Inc | 0.89 | $434.02M |
| UHS Universal Health Services Inc | 6.01 | $8.83B |
| THC Tenet Healthcare Corp | 9.33 | $15.58B |
| MD Mednax Inc | 11.42 | $1.96B |
The price to earnings ratio for MD stock as of Jun 22, 2026, stands at 11.25.
The 3-year average PE ratio for MD stock is 10.6.
The 5-year average PE ratio for MD stock is 12.66.
The highest quarterly PE ratio in the last ten years has been 30.19 and it was in the Mar 2019 quarter.
The current price to earnings ratio of MD is 26% lower than the 10-year historical average.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Mednax's stock price is $23.52. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.09. Therefore, Mednax's P/E ratio for today is 11.25. PE RATIO(11.25) = STOCK PRICE($23.52) / TTM EPS($2.09)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.